Mylan NV said on Tuesday it is addressing issues raised in a warning letter it received earlier this month from the U.S. Food and Drug Administration, which flagged concerns regarding the drugmaker's manufacturing plant in West Virginia.
from Reuters: Health https://ift.tt/2R0NwHC
via
IFTTT
0 comments: